Dental products company Envista Holdings (NYSE:NVST) will be announcing earnings results tomorrow after market close. Here’s what investors should know.
Envista beat analysts’ revenue expectations by 0.8% last quarter, reporting revenues of $652.9 million, up 1.1% year on year. It was a slower quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates.
Is Envista a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Envista’s revenue to decline 2.3% year on year to $609.1 million, a deceleration from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.21 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Envista has missed Wall Street’s revenue estimates four times over the last two years.
Looking at Envista’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Penumbra delivered year-on-year revenue growth of 16.3%, beating analysts’ expectations by 2.7%, and Boston Scientific reported revenues up 20.9%, topping estimates by 2%. Penumbra traded up 7.2% following the results while Boston Scientific was also up 6.5%.
Read our full analysis of Penumbra’s results here and Boston Scientific’s results here.
The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.6% on average over the last month. Envista is down 5.3% during the same time and is heading into earnings with an average analyst price target of $19.83 (compared to the current share price of $16.20).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。